APA (7th ed.) Citation

P, Z., Q, C., & S, O. (2026). Orlistat potentiates the gemcitabine effect in inhibiting the malignant biological behavior of nasopharyngeal carcinoma by downregulating PKM2. Discover oncology, 17(1), . https://doi.org/10.1007/s12672-026-05186-8

Chicago Style (17th ed.) Citation

P, Zhang, Cai Q, and Ouyang S. "Orlistat Potentiates the Gemcitabine Effect in Inhibiting the Malignant Biological Behavior of Nasopharyngeal Carcinoma by Downregulating PKM2." Discover Oncology 17, no. 1 (2026). https://doi.org/10.1007/s12672-026-05186-8.

MLA (9th ed.) Citation

P, Zhang, et al. "Orlistat Potentiates the Gemcitabine Effect in Inhibiting the Malignant Biological Behavior of Nasopharyngeal Carcinoma by Downregulating PKM2." Discover Oncology, vol. 17, no. 1, 2026, https://doi.org/10.1007/s12672-026-05186-8.